About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 450 record(s)
Req # A-2020-000496
All documents in the Management of Executive Correspondence System (MECS) for the following file: 19-117316-857. Subject: British Columbia and Prairie Federal Councils: Amendments to Health Canada's Representation.Organization: Health Canada
July 2020
Req # A-2020-000504
Adverse Reaction Report (AER) for Motrin. Report numbers: 000031447, 000031863, 000032067, 000033019, 000033779, 000043149, 000043401, 000043555, 000044870, 000045278, 000061727, 000063234 , 000063286, 000064024, 000064813, 000178641, 000191081,…Organization: Health Canada
July 2020
Req # A-2020-000507
Adverse Reaction Report (AER) for ALEMTUZUMAB. Report number: 732961.Organization: Health Canada
July 2020
Req # A-2020-000508
Adverse Reaction Report (AER). Report number: 000911669.Organization: Health Canada
July 2020
Req # A-2020-000514
Adverse Reaction Report (AER) for ALIROCUMAB. Report numbers: 731150, E2B_02858852.Organization: Health Canada
July 2020
Req # A-2020-000523
Adverse Reaction Report (AER) for ENOXAPARIN SODIUM. Report number: E2B_02847461.Organization: Health Canada
July 2020
Req # A-2020-000528
Adverse Reaction Report (AER) for HYOSCINE BUTYLBROMIDE. Report numbers: 735705, 735708.Organization: Health Canada
July 2020
Req # A-2020-000532
Adverse Reaction Report (AER) for BENADRYL. Report numbers: 000003300, 000004569, 000090118, 000093028, 000096199, 000097187, 000098746, 000099616, 000099825, 000099911, 000099980, 000101328, 000101475, 000103956, 000104739, 000105742, 000113745,…Organization: Health Canada
July 2020
Req # 19-1919
All e-mail communications, briefs and reports generated as a result of a train accident near Debert, N.S. on the Springhill Sub – on March 20, 2019. Please include all communications generated as a result of media coverage of that incident as well.…Organization: VIA Rail Canada Inc.
July 2020
Req # 19-1981
Obtain copies of all correspondence/communications sent and received by the following persons from VIA Rail (Cynthia Garneau, President and Chief Executive Officer, Marc Beaulieu, Chief, Transportation and Security, Ben Marc Diendéré, Chief, Public…Organization: VIA Rail Canada Inc.
July 2020